PYC Therapeutics: Lands FDA clearance for first human trials of RP11 treatment drug
PYC Therapeutics Lands FDA clearance for first human trials of RP11 treatment drugPYC Pharmaceuticals (PYC) lands approval from the US FDA to begin...
PYC Therapeutics: Completes VP-001 toxicology studies, eyes human trials
PYC Therapeutics Completes VP-001 toxicology studies, eyes human trialsPYC Therapeutics (PYC) completes single-dose toxicology of its investigational Retinitis Pigmentosa type 11 (RP11) treatment...

